Navigation Links
UQ health and medical researchers recognized in awards
Date:12/12/2007

Three researchers from The University of Queensland have been recognised in the inaugural National Health and Medical Research Council (NHMRC) Awards.

Professors John Hancock and Robert Parton, both from UQs Institute for Molecular Bioscience (IMB) and Dr David Copland from the School of Health & Rehabilitation Sciences were among a select group of winners honoured at a ceremony held tonight (Wednesday, December 12) in Canberra.

The NHMRC Awards recognise a number of outstanding Australians for their contributions to health and medical research. The awards are designed to show the NHMRCs appreciation to the research and ethics community for their considerable scientific research, innovation and leadership. Professor David Siddle, UQs Deputy Vice-Chancellor (Research), said the awards were testament to the outstanding work of the three researchers in areas that will one day improve the health of many people.

These awards recognise the ground-breaking work of three outstanding researchers, Professor Siddle said.

In addition to the fundamental research, these talented researchers are working on solutions to problems such as cancer, muscular dystrophy and treatments for brain injury and disease.

Professors Hancock and Parton received the NHMRC Achievement Award Program Grant, which recognises their work in studying the surface of the cell.

Far from being a smooth, uniform area, the cell surface is actually organised into different domains with distinct functions. The researchers will map these domains and identify their functions, which should allow the development of therapeutic strategies aimed at combating the changes associated with cell transformation in cancer and other human diseases such as muscular dystrophy.

Professor Hancock is the Deputy Director (Research) of the IMB and a world authority on Ras proteins, which are located on the underside of the cell membrane and play a role in triggering 30 percent of all human tumours.

Professor Parton is an expert on caveolae, small pits in the cell surface, which have been linked to muscular dystrophy, liver regeneration and obesity. The two recently received a $5 million Program Grant to support their study.

Dr Copland received the NHMRC Achievement Award Career Development Award - Clinical Level 2 (Senior researcher 7-12 years post Doctorate), which recognises his work to understand the effects of neurological injury or disease on language and to shed light on the brain mechanisms underpinning language treatment and recovery.

He is internationally recognised for research that has significantly increased our understanding of the effects of stroke and neurodegenerative diseases on language and communication. He is also involved in training a large cohort of PhD students as future researchers in this area.

His current work seeks to map the brain mechanisms associated with language treatments and to identify how to optimise language function after neurological damage.


'/>"/>
Contact: Andrew Dunne
613-365-2802
Research Australia
Source:Eurekalert

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Air pollution linked to cardiovascular risk indices in healthy young adults
4. More proof needed of safety and quality of electronic personal health records
5. Health care incentive model offers collaborative approach
6. Loneliness is bad for your health
7. Mailman School of Public Health study examines link between racial discrimination and substance use
8. Green Tea May Brew Up Healthier Skin
9. For Health Info, Women Often Turn to the Web
10. Record Number of Americans Lack Health Insurance
11. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's (ABFM) Board ... Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will ... Dr. Puffer’s retirement at the end of 2018. Upon assuming the role of President ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... a national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel ... also provides a forum to network with elder law attorneys nationwide,” said Somekh. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/25/2017)... AMSTERDAM , Sept. 25, 2017   ... Trial Master File solutions, today—from the IQPC Trial ... Amsterdam , NL)—announced that EastHORN Clinical Services ... its clinical programs and TMF management. EastHORN, a ... Montrium,s eTMF platform to increase transparency to enable ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: